Esther van Meerten

Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer

Rutger C. H. Stijns, Eelco J. R. de Graaf, Cornelis J.A. Punt et al. · JAMA Surgery · 2018 · 224 citations · Full text

Medicine, Oncology, Surgery +16

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 111 citations · Full text

Medicine, Oncology, Surgery +14

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery

Guus M.J. Bökkerink, Eelco JR de Graaf, Cornelis J.A. Punt et al. · BMC Surgery · 2011 · 81 citations · Full text

Medicine, Oncology, Surgery +17

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases

Koen P. Rovers, Checca Bakkers, Simon W. Nienhuijs et al. · JAMA Surgery · 2021 · 73 citations · Full text

Medicine, Perioperative Medicine, Surgery +17